The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(1-(4-Chlorobenzyl)-2-methyl-1H-indol-3-yl)-3-(pyridin-4-yl)-4,5-dihydroisoxazole ID: ALA4248105
PubChem CID: 145983601
Max Phase: Preclinical
Molecular Formula: C24H20ClN3O
Molecular Weight: 401.90
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(C2CC(c3ccncc3)=NO2)c2ccccc2n1Cc1ccc(Cl)cc1
Standard InChI: InChI=1S/C24H20ClN3O/c1-16-24(23-14-21(27-29-23)18-10-12-26-13-11-18)20-4-2-3-5-22(20)28(16)15-17-6-8-19(25)9-7-17/h2-13,23H,14-15H2,1H3
Standard InChI Key: NSNLIHHZBKOFEZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
2.5327 -29.7573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5316 -30.5768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2396 -30.9858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2378 -29.3484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9464 -29.7537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9467 -30.5769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7297 -30.8310 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2134 -30.1649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7292 -29.4991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1301 -28.7874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9512 -28.8095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2244 -28.0397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5767 -27.5419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9032 -28.0042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0411 -28.0363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4505 -28.7441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2664 -28.7410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6725 -28.0315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2569 -27.3237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4423 -27.3303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7215 -31.6476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0098 -32.0491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3089 -31.6293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5976 -32.0301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5891 -32.8482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2977 -33.2637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0060 -32.8604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8779 -33.2507 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.0306 -30.1646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
12 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
7 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
25 28 1 0
8 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 401.90Molecular Weight (Monoisotopic): 401.1295AlogP: 5.91#Rotatable Bonds: 4Polar Surface Area: 39.41Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 3.87CX LogP: 5.27CX LogD: 5.27Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.43Np Likeness Score: -1.13
References 1. Chaitanya MVSK, Reddy POV, Nikhil K, Kumar A, Shah K, Kumar D.. (2018) Synthesis and anticancer activity studies of indolylisoxazoline analogues., 28 (17): [PMID:30072225 ] [10.1016/j.bmcl.2018.07.035 ]